As chronic pancreatic injury is associated with high neoplastic risk, loss of EZH2 promotes neoplastic progression, which is also demonstrated by the mice experiment that loss of EHZ2 accelerates KRasG12D-driven neoplasia [38]. Here, EZH2 is linked to neoplasm.